Desmopressin EP Dydrogesterone Impurity B is a recognized impurity standard associated with desmopressin formulations. Variations in oxidation or processing conditions generate measurable changes in chromatographic signature. Researchers use it to evaluate specificity of impurity-profiling methods. Applications include stability-indicating assay development, impurity assignment, and structural characterization.
CAT No: R2765
CAS No:1162-56-7
Synonyms/Alias:6-Dehydroprogesterone; Pregna-4,6-diene-3,20-dione; 1162-56-7; Delta-6-progesterone; .delta.6-Progesterone; 4,6-Pregnadiene-3,20-dione; Dydrogesterone impurity B; UNII-EF38VA583P; delta6-Progesterone; EF38VA583P; 6-Dehydropregesteron; (8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one; PROGESTERONE IMPURITY H [EP IMPURITY]; DYDROGESTERONE IMPURITY B [EP IMPURITY]; MFCD00199858; PROGESTERONE IMPURITY H (EP IMPURITY); DYDROGESTERONE IMPURITY B (EP IMPURITY); SCHEMBL606817; Pregna-4,6-diene-3,20-dione (Delta6-Progesterone); CHEMBL4101936; BCP18804; AKOS015902046; AC-4529; FD32696; AS-15619; CS-0155158; P2623; Pregna-4,6-diene-3,20-dione (?6-Progesterone); Q27277145
Desmopressin EP Dydrogesterone impurity B is a specialized carbohydrate compound utilized extensively in pharmaceutical research and development. Characterized by its unique molecular structure, this impurity is often encountered during the synthesis and analysis of dydrogesterone, a well-known synthetic progestogen. The compound stands out due to its relevance in impurity profiling, providing researchers with an essential reference for method validation, stability studies, and analytical characterization. Its availability as a research-grade material makes it indispensable for laboratories focused on the quality control and comprehensive study of steroidal pharmaceuticals. By serving as a critical analytical standard, Desmopressin EP Dydrogesterone impurity B supports the advancement of pharmaceutical sciences and ensures the reliability of various investigational procedures.
Impurity Profiling: In the context of impurity profiling, Desmopressin EP Dydrogesterone impurity B is frequently employed as a reference compound to identify and quantify trace levels of related substances in dydrogesterone formulations. Analytical chemists utilize it to develop and refine chromatographic methods, such as HPLC and LC-MS, enabling precise detection and differentiation of impurities. This process is vital for elucidating the impurity profile of active pharmaceutical ingredients, ensuring that the synthesis process is well-characterized, and supporting the development of safer and more effective therapeutic agents. The presence of this impurity reference aids in the interpretation of complex chromatograms and facilitates the establishment of robust analytical procedures.
Analytical Method Validation: The compound plays a crucial role in the validation of analytical methods designed to monitor the purity and stability of dydrogesterone. By incorporating Desmopressin EP Dydrogesterone impurity B into validation protocols, scientists can assess parameters such as accuracy, precision, specificity, and detection limits. This ensures that the analytical techniques employed are reliable and reproducible, which is essential for routine quality control and regulatory submissions. The use of this impurity standard helps laboratories demonstrate the capability of their analytical methods to consistently detect and quantify related substances, thereby enhancing the overall quality assurance process.
Stability Studies: Stability testing is a fundamental aspect of pharmaceutical development, and Desmopressin EP Dydrogesterone impurity B serves as a key marker for monitoring the degradation pathways of dydrogesterone under various environmental conditions. Researchers incorporate this impurity into forced degradation studies to simulate long-term storage and stress scenarios, allowing them to identify potential degradation products and assess the chemical stability of the drug substance. The insights gained from these studies inform formulation strategies and packaging decisions, ultimately contributing to the development of more stable and reliable pharmaceutical products.
Pharmaceutical Research and Development: Within pharmaceutical R&D, the presence of Desmopressin EP Dydrogesterone impurity B enables scientists to investigate the synthesis pathways and optimize reaction conditions for dydrogesterone production. By tracking the formation and elimination of this impurity, process chemists can refine synthetic routes to minimize unwanted byproducts and enhance overall yield. This not only streamlines manufacturing processes but also supports the creation of high-purity active ingredients, reducing the risk of adverse effects associated with impurity exposure.
Reference Standard for Instrument Calibration: Laboratories frequently utilize this carbohydrate compound as a reference standard for calibrating analytical instruments. Accurate calibration is essential for obtaining reproducible and trustworthy results in impurity quantification and method validation. By providing a consistent and well-characterized standard, Desmopressin EP Dydrogesterone impurity B helps ensure that instruments such as HPLC and mass spectrometers are functioning optimally, thereby supporting the integrity of analytical data and facilitating compliance with internal quality requirements. Through its multifaceted applications, this impurity reference plays an integral role in advancing analytical science and pharmaceutical quality control.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.